Begin main content

Call for Nominations Now Open for CADTH Advisory and Expert Committees

March 18, 2019
CADTH is seeking nominations for its advisory and expert committees. If you have significant expertise in the Canadian health care system, are interested in helping support health care decision-makers in making informed choices about health technologies, and are passionate about ensuring that the Canadian health care system is the best it can be...

New at CADTH - March 2019

March 8, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Call for Patient Input and Clinical Experts: Iluvien

March 6, 2019
CADTH has received the following notice(s) of pending drug submission(s).  Brand name Iluvien Generic name fluocinolone acetonide intravitreal implant Manufacturer Knight Therapeutics Inc. Indication(s) diabetic macular edema Project Number SR0608-000 Call for patient input 2019-03-06 Patient input deadline 2019-04-25 Submit patient input Submit...

Call for Patient Input and Clinical Experts: Translarna

March 5, 2019
CADTH has received the following notice(s) of pending drug submission(s).  Brand name Translarna Generic name ataluren Manufacturer PTC Therapeutics Canada ULC Indication(s) Dystrophinopathy Project Number SR0607-000 Call for patient input 2019-03-05 Patient input deadline 2019-04-24 Submit patient input Submit Register as Clinical Expert Regis...

Call for Patient Input and Clinical Experts: Revestive

March 4, 2019
CADTH has received the following notice(s) of pending drug submission(s).  Brand name Revestive Generic name teduglutide Manufacturer Shire Pharmaceuticals Ireland Limited Indication(s) Short Bowel Syndrome (SBS), pediatrics Project Number SR0606-000 Call for patient input 2019-03-04 Patient input deadline 2019-04-23 Submit patient input Submit...